Sanofi Eyes €1 billion Eye-Care Acquisitions

14.02.2011 - Sanofi-Aventis, the French drugmaker whose $18.5 billion bid for U.S. biotech Genzyme expires on Tuesday, is studying four acquisitions in the ophthalmology sector, Les Echos...